The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global advanced wound care market size reached US$ 9.32 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 13.56 Billion by 2027, exhibiting a growth rate (CAGR) of 6.12% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Advanced wound care is a standard medical solution that provides specialized treatment for chronic infections and non-healing wounds by removing dead and inflamed tissues. It includes medications, equipment, and several products that help treat acute and chronic wounds, such as burns, ulcers, and post-operative wounds. Advanced wound care products comprising silver and alginates are extensively used to remove excess fluids from wounds and protect them from infections. They include hydrogels, hydrocolloids, film and foam dressings, and alginates. They help retain skin moisture and facilitate quick healing of wounds internally and externally by promoting the growth of body cells.
The increasing global geriatric population and the rising prevalence of pressure ulcers, diabetic foot ulcers, and other chronic wounds are among the key factors positively influencing the market. Chronic wounds are complex and non-healing infections that fail to progress through the healing phases in an orderly sequence. In addition, the increasing occurrence of diabetes, obesity, and a significant surge in the need for surgical procedures across the globe are catalyzing the demand for advanced wound care products as they help absorb necrotic tissues, which are highly effective in the rapid healing of surgical site infections. In line with this, the rising awareness among individuals about the proven benefits and effectiveness of these products is increasing their sales worldwide. Apart from this, technological advancements in advanced wound care products are contributing to market growth. For instance, nanoparticle-based wound healing and skin regeneration bioactive molecules over the applied area maintain the drug release and improve the therapeutic effects of drugs. Furthermore, the expansion of Ambulatory Surgical Centers (ASCs) that provide diagnostics, preventive procedures, and surgical care for pain management, orthopedics, urology, restorative, organ transplantation, and reconstructive surgeries, is propelling the market growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global advanced wound care market report, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on product, application and end user.
Breakup by Product:
Breakup by Application:
Breakup by End User:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being 3M Company, B. Braun SE (B. Braun Holding GmbH & Co. KG), Cardinal Health, Inc., Coloplast A/S, Convatec Group plc, Essity AB, Integra LifeSciences, Medline Industries, LP, Medtronic plc, Mölnlycke Health Care (Investor AB), Organogenesis Holdings Inc. and Smith & Nephew plc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Application, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||3M Company, B. Braun SE (B. Braun Holding GmbH & Co. KG), Cardinal Health, Inc., Coloplast A/S, Convatec Group plc, Essity AB, Integra LifeSciences, Medline Industries, LP, Medtronic plc, Mölnlycke Health Care (Investor AB), Organogenesis Holdings Inc. and Smith & Nephew plc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at